Salem Almaani

Salem Almaani's research focuses on kidney diseases, particularly glomerular disorders such as diabetic kidney disease, ANCA-associated vasculitis, lupus nephritis, and membranous nephropathy. His work often involves large collaborative patient registries and cohort studies (such as CureGN and TRIDENT) that track disease progression, treatment outcomes, and risk factors, as well as newer methods like tissue imaging and computational analysis of kidney biopsy samples. Prospective students would likely be involved in clinical and translational research combining patient data, biopsy-based studies, and multi-center registries.

Publication output rose sharply from 2017 to a peak around 2020-2023, followed by a modest decline in the last two to three years, though output remains substantially higher than a decade ago.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026